Trading November 3, 2026

CVS Health plans two-company split, WSJ says

CVS Health plans two-company split, WSJ says
CVS Healthcompany splitretail pharmacyAetnapharmacy benefit managershealthcare consolidationWSJ report

Nov 3 (Reuters) – CVS Health is set to separate into two businesses, splitting its retail pharmacy arm from its insurance and pharmacy-benefit operations, the Wall Street Journal reported on Tuesday.

Citing the company, the Journal said one of the resulting companies will keep the CVS Health name and be headed by David Joyner, its current CEO.

CVS Health, scheduled to release quarterly results on Wednesday, did not immediately reply to a Reuters request for comment.

Such a split would represent a major reversal of CVS’s strategy of assembling an integrated healthcare company through acquisitions, including the roughly $78 billion acquisition of insurer Aetna in 2018.

The company’s shares rose 1.2% in extended trading.

The Financial Times had earlier reported that CVS was weighing a spin-off of its retail pharmacy business—which runs about 9,000 pharmacies—into a separately listed company, while Aetna and its pharmacy-benefit manager Caremark would stay together.

The possible restructuring comes as pharmacy benefit managers face increasing political and regulatory scrutiny over their role in the U.S. drug supply chain, drawing attention to healthcare companies that combine insurance, drug-benefit management and pharmacy operations.

The company reported record revenue of $402.1 billion in 2025, an increase of 7.8% from the previous year.

Reuters reported at the time that CVS had explored options, including a possible breakup, in 2024 as the healthcare giant dealt with challenges across its businesses.

CVS shares have recovered under Joyner, who became CEO in October 2024, helping raise the company’s market value to about $117 billion.

FractLab Unlock Your Edge A proprietary strategy built to surface hidden opportunities others miss. FractLab Trade with FractLab Multi-timeframe trend detection, accumulation filters and adaptive position scaling. FractLab Try it with a guarantee Full TradingView toolkit access. 30-day money back if it is not for you. Try